FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products

Go back to FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products

BofA on Philip Morris (PM): 'one of the best positioned companies in the consumer staples sector'

June 30, 2026 1:09 PM EDT

BofA Securities analyst Lisa Lewandowski reiterated a Buy rating and $209.00 price target on Philip Morris (NYSE: PM).

The analyst comments "MRTP orders are important because the applications undergo strict, science-based testing for any tobacco product that claims to be less harmful than others. Before a manufacturer can market a product with reduced-risk or reduced-exposure claims, it must obtain an... More